{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:57:55Z","timestamp":1790906275655,"version":"4.1.0"},"reference-count":145,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetic macular oedema (DME) is considered a chronic inflammatory disease associated with aberrations in many intraocular cytokines. Studies assessing the role of these cytokines as biomarkers in the diagnosis and management of DME have demonstrated inconsistent findings. We quantitatively summarized data related to 116 candidate aqueous and vitreous inflammatory cytokines as biomarkers in DME. A systematic search without year limitation was performed up to 19 October 2020. Studies were included if they provided data on aqueous or vitreous cytokine concentrations in patients with DME. Effect sizes were generated as standardized mean differences (SMDs) of cytokine concentrations between patients with DME and controls. Data were extracted from 128 studies that included 4163 study eyes with DME and 1281 control eyes. Concentrations (standard mean difference, 95% confidence interval and p\u2010value) of aqueous IL\u20106 (1.28, 0.57\u20132.00, p\u2009=\u20090.004), IL\u20108 (1.06, 0.74\u20131.39, p\u2009&lt;\u20090.00001), MCP\u20101 (1.36, 0.57\u20132.16, p\u2009=\u20090.0008) and VEGF (1.31, 1.01\u20131.62, p\u2009&lt;\u20090.00001) and vitreous VEGF (2.27, 1.55\u20132.99, p\u2009&lt;\u20090.00001) were significantly higher in patients with DME (<jats:italic>n<\/jats:italic>\u2009=\u20094163) compared to healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u20091281). No differences, failed sensitivity analyses or insufficient data were found between patients with DME and healthy controls for the concentrations of the remaining cytokines. This analysis implicates multiple cytokine biomarker candidates other than VEGF in DME and clarifies previously reported inconsistent associations. As the therapeutic options for DME expand to include multiple agents with multiple targets, it will be critical to manage the treatment burden with tailored therapy that optimizes outcomes and minimizes treatment burden. Intraocular cytokines have the promise of providing a robust individualized assessment of disease status and response to therapy. We have identified key candidate cytokines that may serve as biomarkers in individualized treatment algorithms.<\/jats:p>","DOI":"10.1111\/aos.14891","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T16:21:37Z","timestamp":1620145297000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"100","author":[{"given":"Samuel A.","family":"Minaker","sequence":"first","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan H.","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-7954","authenticated-orcid":false,"given":"Gabriela","family":"Lahaie Luna","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Queen\u2019s University Kingston Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Farahvash","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishaant","family":"Bhambra","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bapat","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-6472","authenticated-orcid":false,"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology St. Michael\u2019s Hospital\/Unity Health Toronto Toronto Canada"},{"name":"Department of Ophthalmology &amp; Vision Sciences University of Toronto Toronto Canada"},{"name":"Kensington Vision and Research Centre Toronto Canada"},{"name":"University of Toronto\/Kensington Health Ophthalmology Biobank and Cytokine Laboratory Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-9233.57682","article-title":"Vitreous, aqueous, and serum levels of vascular endothelial growth factor and angiopoietin\u20102 in patients with proliferative diabetic retinopathy and diabetic macular edema","volume":"14","author":"Abdel Rasol HA","year":"2007","journal-title":"Middle E J Ophthalmol"},{"key":"e_1_2_8_3_1","first-page":"276","article-title":"Longitudinal changes in aqueous humor cytokines in diabetic macular edema treated with anti\u2010vascular endothelial growth factor therapy","volume":"61","author":"Abraham JR","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.08.047"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300139"},{"key":"e_1_2_8_6_1","first-page":"241","article-title":"Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography","volume":"38","author":"Bandyopadhyay S","year":"2018","journal-title":"Int Ophthalmol"},{"key":"e_1_2_8_7_1","first-page":"4679","article-title":"Correlation of aqueous cytokines with OCT appearance in patients with diabetic macular oedema","volume":"56","author":"Brelen ME","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.12.1801"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-4169-4"},{"key":"e_1_2_8_10_1","first-page":"1314","article-title":"Collection of spontaneous vitreous reflux following intravitreal injection: a comparison of sampling methods","volume":"55","author":"Cacciamani A","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.038"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.04.017"},{"key":"e_1_2_8_13_1","first-page":"40","article-title":"Association of aqueous cytokine profile and extracted OCT features in diabetic macular edema: Assessment of the anatomic\u2010biologic bridge","volume":"61","author":"Cardwell N","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_14_1","first-page":"1005","article-title":"Increased levels of IL\u20106, sIL\u20106R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy","volume":"22","author":"Chen H","year":"2016","journal-title":"Mol Vis"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13750"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222364"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2013.02.004"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2019.1665187"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.03.024"},{"key":"e_1_2_8_20_1","first-page":"4873","article-title":"Reduced vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (FAc, ILUVIEN) implant in patients with persistent or recurrent DME \u2010 results from the ILUVIT study","volume":"61","author":"Deuchler S","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125329"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.07.034"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.04.002"},{"key":"e_1_2_8_24_1","first-page":"2425","article-title":"Differences in aqueous concentrations of various cytokines in macular edema due to non\u2010proliferative and proliferative diabetic retinopathy","volume":"54","author":"Feng J","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_25_1","volume-title":"Cytokines in pathogenesis of persistent diabetic macular edema","author":"Fidranska H","year":"2013"},{"key":"e_1_2_8_26_1","first-page":"4826","article-title":"Aqueous humour cytokine levels may predict diabetic macular edema response to intravitreal dexamethasone implant injection","volume":"59","author":"Figueras\u2010Roca M","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1636095"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-26215"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.181222"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.037"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00568-2"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01971-2"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.10.030"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-0950-7"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01269-7"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.11.045"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181e095c0"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22731"},{"key":"e_1_2_8_39_1","first-page":"4716","article-title":"Vitreous levels of VEGF A and its receptors do not correlate with severity of diabetic macular edema","volume":"56","author":"Gauthier AF","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18721"},{"key":"e_1_2_8_41_1","first-page":"4715","article-title":"Vitreous levels of TNF\u03b1R are inversely related to severity of diabetic macular edema","volume":"56","author":"Glaser BM","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_42_1","first-page":"2027","article-title":"Pretreatment levels of vitreous protein biomarkers correlate with visual acuity outcome in response to intravitreal triamcinolone in Diabetic Macular Edema","volume":"58","author":"Glaser BM","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-4-201302190-00009"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001210"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.0179"},{"key":"e_1_2_8_46_1","first-page":"3660","article-title":"One year follow\u2010up data on changes in aqueous VEGF levels in eyes with diabetic macula edema treated with ranibizumab using the pro re nata regimen","volume":"60","author":"Hirano T","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018333"},{"key":"e_1_2_8_48_1","first-page":"53","article-title":"Anti\u2010VEGF therapy reduces inflammation in diabetic macular edema","volume":"64","author":"Imazeki M","year":"2020","journal-title":"Ophthalmic Res"},{"key":"e_1_2_8_49_1","first-page":"4717","article-title":"Alterations in VEGF, PEDF, PDGF levels of vitreous and blood in response to intravitreal anti\u2010VEGF therapy in patients with diabetic macular edema","volume":"56","author":"Inan UU","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000109"},{"key":"e_1_2_8_51_1","doi-asserted-by":"crossref","unstructured":"JonasJB JonasRA NeumaierM FindeisenP(2011):Cytokine concentration in aqueous humor of eyes with diabetic macular edema. American Academy of Ophthalmology 2011 Annual Meeting Orlando FL USA.","DOI":"10.1111\/j.1755-3768.2011.2217.x"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2006.01437.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1159\/000102935"},{"key":"e_1_2_8_54_1","first-page":"1955","article-title":"The association of aqueous cytokines with long\u2010term response to intravitreal ranibizumab in diabetic macular edema","volume":"59","author":"Juncal V","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2020.0038"},{"key":"e_1_2_8_56_1","first-page":"4714","article-title":"Vitreous proteomics demonstrates that TGF\u03b2 and TGF\u03b2R parallel severity of diabetic macular edema","volume":"56","author":"Katz MSJ","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_57_1","first-page":"4181","article-title":"Analysis of aqueous cytokines according to na\u00efve diabetic macular edema patterns as based on optical coherence tomography","volume":"57","author":"Kim JY","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.158069"},{"key":"e_1_2_8_59_1","first-page":"145","article-title":"Glucose\u2010regulated protein 78 in the aqueous humour of patients with diabetic macular oedema","volume":"47","author":"Kim M","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-017-0525-x"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.2337\/db15-0317"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1034804"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/459251"},{"key":"e_1_2_8_64_1","first-page":"5374","article-title":"Glucose\u2010regulated protein 78 in the aqueous humor in diabetic macular edema patients","volume":"59","author":"Kwon J","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203408"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012757"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.01.007"},{"key":"e_1_2_8_68_1","first-page":"2068","article-title":"Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema","volume":"57","author":"Lee SJ","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-301913"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2011.02510.x"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23325"},{"key":"e_1_2_8_72_1","first-page":"225","article-title":"Aqueous levels of VEGF correlate with retinal non\u2010perfusion areas in patients with diabetic macular edema and macular edema secondary to central retinal vein occlusion","volume":"117","author":"Machalinska A","year":"2016","journal-title":"Klin Oczna"},{"key":"e_1_2_8_73_1","first-page":"833","article-title":"Effect of intravitreal bevacizumab on macular thickness: exploring serum and vitreous proangiogenic biomarkers in patients with diabetic macular edema","volume":"48","author":"Malik TG","year":"2018","journal-title":"Turk J Med Sci"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35036-9"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20539"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(02)00508-7"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.4914"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.84.3.332"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190328"},{"key":"e_1_2_8_80_1","first-page":"3861","article-title":"Subthreshold micropulse laser treatment of human diabetic macular edema: the role of M\u00fcller cells, retinal pigment epithelium and the inflammatory cascade","volume":"60","author":"Midena E","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46515-y"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1177\/2474126419880391"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14537"},{"key":"e_1_2_8_84_1","first-page":"5398","article-title":"Bridging the divide: Aqueous humour biomarkers and tomographic morphology in diabetic macular edema","volume":"57","author":"Modi A","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_8_86_1","first-page":"196","article-title":"VEGF\u2010A expression under prodiabetic conditions in human retinal and endothelial cells and the vitreous fluid of patients with type 2 diabetes","volume":"210","author":"Morawietz H","year":"2014","journal-title":"Acta Physiol"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303954"},{"key":"e_1_2_8_88_1","first-page":"4867","article-title":"Correlation of ultra\u2010widefield fluorescein angiographic features with intraocular cytokine expression in diabetic macular edema: Exploring the angiographic\u2010biologic phenotype","volume":"61","author":"Mugnaini CJ","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_89_1","first-page":"4680","article-title":"Molecular analysis of ocular inflammatory pathways driving diabetic retinopathy patients undergoing anti\u2010VEGF therapy","volume":"56","author":"Nagaraj S","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1159\/000475603"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000364955"},{"key":"e_1_2_8_92_1","first-page":"3245","article-title":"Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in diabetic macular edema","volume":"57","author":"Noma H","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_93_1","first-page":"4407","article-title":"Different concentrations of aqueous cytokines according to optical coherence tomographic patterns in patients with diabetic macular edema","volume":"55","author":"Park SP","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8137417"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.049940"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702584"},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.10.002"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.02030.x"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14297"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2742"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.0972"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.036"},{"key":"e_1_2_8_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-020-00234-z"},{"key":"e_1_2_8_104_1","first-page":"4842","article-title":"Relationship between cytokine aqueous humour levels and optical coherence tomography features in diabetic macular edema","volume":"59","author":"Sala\u2010Puigdollers A","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_105_1","first-page":"942","article-title":"Reduction of aqueous levels of VEGF after sequential intravitreal injections of aflibercept in diabetic macular edema","volume":"58","author":"Sambhav K","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.10.1363"},{"key":"e_1_2_8_107_1","unstructured":"SchmidtM TisdaleA LowdenP KovalchinJ&FurfineES(2014):Optimized IL\u20106 blockade for the treatment of diabetic macular edema. Abstract. Association for Research in Vision & Ophthalmology (ARVO) Annual Meeting Orlando Florida."},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.67042"},{"key":"e_1_2_8_109_1","first-page":"1150","article-title":"Effect of intravitreal ranibizumab administration on aqueous levels of IL8 and IL6 in patients with diabetic macular edema","volume":"54","author":"Sepah Y","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_110_1","first-page":"1149","article-title":"To determine changes in levels of cytokines in the anterior chamber (AC) fluid of eyes in patients with diabetic macular edema (DME) whom have been treated with repeated injections of ranibizumab (RBZ)","volume":"54","author":"Sepah Y","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_111_1","first-page":"4938","article-title":"Trends for poorer vision outcomes in nAMD and DME patients with higher aqueous humor levels of IL\u20106","volume":"60","author":"Sepah YJ","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_112_1","first-page":"29","article-title":"Intraocular cytokines concentrations in patients with different levels of activity of retinal pathologies","volume":"232","author":"Shchuko AG","year":"2014","journal-title":"Ophthalmologica"},{"key":"e_1_2_8_113_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2870"},{"key":"e_1_2_8_114_1","first-page":"4702","article-title":"Dynamic change of aqueous concentrations of cytokines and their receptors during the clinical course of ranibizumab treatment in diabetic macular edema","volume":"56","author":"Shimura M","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_115_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309953"},{"key":"e_1_2_8_116_1","first-page":"4997","article-title":"Micro RNAs in the aqueous humor of patients with diabetic macular edema","volume":"61","author":"Shin YU","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_117_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174340"},{"key":"e_1_2_8_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13232"},{"key":"e_1_2_8_119_1","first-page":"4829","article-title":"Aqueous humor cytokine levels in patients with diabetic macular edema refractory to intravitreal anti\u2010VEGF treatment and a dexamethasone implant","volume":"59","author":"Sim YS","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_120_1","first-page":"4879","article-title":"The correlation between the expression of cytokines and growth factors and the clinical stage of diabetic retinopathy in patients with DME \u2010 results from the ILUVIT study, a single center, phase IV study","volume":"61","author":"Singh P","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_121_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120879"},{"key":"e_1_2_8_122_1","first-page":"305","article-title":"ANGPTL4 and VEGF cooperate to promote diabetic macular edema","volume":"61","author":"Sodhi SM","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.03.033"},{"key":"e_1_2_8_124_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12382"},{"key":"e_1_2_8_125_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12382"},{"key":"e_1_2_8_126_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182a48917"},{"key":"e_1_2_8_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.285"},{"key":"e_1_2_8_128_1","first-page":"2072","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal ranibizumab for diabetic macular edema","volume":"57","author":"Toriyama Y","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12363"},{"key":"e_1_2_8_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111841"},{"key":"e_1_2_8_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31826f0688"},{"key":"e_1_2_8_132_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S222004"},{"key":"e_1_2_8_133_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306341"},{"key":"e_1_2_8_134_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009"},{"key":"e_1_2_8_135_1","first-page":"4839","article-title":"The influence of intravitreal ranibizumab on aqueous cytokine concentrations in diabetic macular edema","volume":"59","author":"Wickremasinghe S","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_136_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6928524"},{"key":"e_1_2_8_137_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16854"},{"key":"e_1_2_8_138_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2019.1570274"},{"key":"e_1_2_8_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-018-0874-6"},{"key":"e_1_2_8_140_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14248"},{"key":"e_1_2_8_141_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.055053"},{"key":"e_1_2_8_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306366"},{"key":"e_1_2_8_143_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008158"},{"key":"e_1_2_8_144_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3819-2"},{"key":"e_1_2_8_145_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20657"},{"key":"e_1_2_8_146_1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.111184"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14891","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aos.14891","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:49:29Z","timestamp":1724993369000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.14891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":145,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/aos.14891"],"URL":"https:\/\/doi.org\/10.1111\/aos.14891","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"2021-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}